
Whoop’s FDA warning letter sparks debate over blood pressure as a wellness metric
A warning letter sent by the Food and Drug Administration to wearable company Whoop has sparked a debate on when wellness claims should be regulated as medical devices. Whoop, a company selling a wearable wristband to track metrics such as sleep, heart …